AI assistant
Xilio Therapeutics, Inc. — Director's Dealing 2021
Nov 5, 2021
34726_dirs_2021-11-05_401ea2d6-3907-4c6d-85d7-f776efda347e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Xilio Therapeutics, Inc. (XLO)
CIK: 0001840233
Period of Report: 2021-10-26
Reporting Person: Bain Capital Life Sciences Investors, LLC (10% Owner)
Reporting Person: Bain Capital Life Sciences Fund II, L.P. (10% Owner)
Reporting Person: Bain Capital Life Sciences Investors II, LLC (10% Owner)
Reporting Person: BCLS II Investco, LP (10% Owner)
Reporting Person: BCLS II Investo (GP), LLC (10% Owner)
Reporting Person: BCIP Life Sciences Associates, LP (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2762944 | Indirect |
Footnotes
F1: Represents 1,348,682 shares of the Issuer's common stock held by Bain Capital Life Sciences Fund II, L.P. ("BCLS II"), 1,250,000 shares of the Issuer's common stock held by BCLS II Investco, LP ("BCLS II Investco") and 164,262 shares of the Issuer's common stock held by BCIP Life Sciences Associates, LP ("BCIPLS" and, together with BCLS II and BCLS II Investco, the "Bain Capital Life Sciences Entities").
F2: Bain Capital Life Sciences Investors II, LLC ("BCLSI II") is the general partner of BCLS II. As a result, BCLSI II may be deemed to share voting and dispositive power with respect to the securities held by BCLS II. BCLSI II disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
F3: BCLS II Investco (GP), LLC ("BCLS II Investco GP"), whose manager is BCLS II, is the general partner of BCLS II Investco. As a result, each of BCLSI II, BCLS II and BCLS II Investco GP may be deemed to share voting and dispositive power with respect to the securities held by BCLS II Investco. Each of BCLSI II, BCLS II and BCLS II Investco GP disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
F4: Boylston Coinvestors, LLC is the general partner of BCIPLS.
F5: Bain Capital Life Sciences Investors, LLC ("BCLSI") is the manager of BCLSI II and governs the investment strategy and decision-making process with respect to investments held by BCIPLS. As a result, BCLSI may be deemed to share voting and dispositive power with respect to the securities held by the Bain Capital Life Sciences Entities. BCLSI disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.